Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Asacol Acute Diverticulitis(DIVA)Study

ClinicalTrials.gov ID: NCT00554099

Public ClinicalTrials.gov record NCT00554099. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 8:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of a 12 Week Treatment of Acute Diverticulitis With Asacol® 2.4 g/Day (400 mg Mesalamine Tablet), Followed by a 9 Month Treatment-free Observation Period

Study identification

NCT ID
NCT00554099
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Warner Chilcott
Industry
Enrollment
117 participants

Conditions and interventions

Conditions

Interventions

  • Mesalamine Drug
  • Probiotic Drug
  • Placebo Drug
  • Dietary Advice Other
  • Antibiotic for Diverticulitis Drug

Drug · Other

Eligibility (public fields only)

Age range
35 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2007
Primary completion
Feb 28, 2010
Completion
Feb 28, 2010
Last update posted
Apr 21, 2013

2007 – 2010

United States locations

U.S. sites
36
U.S. states
17
U.S. cities
36
Facility City State ZIP Site status
Research Site Tucson Arizona
Research Facility Los Angeles California
Research Site Merced California
Research Site Oakland California
Research Facility Orange California
Research Site Palm Springs California
Research Site Pasadena California
Research Site Lafayette Colorado
Research Site Littleton Colorado
Research Site Boynton Beach Florida
Research Site Jacksonsville Florida
Research Site Jacksonville Florida
Research Site Winter Park Florida
Research Facility Zephyrhills Florida
Research Site Pratt Kansas
Research Site Monroe Louisiana
Research Site Shreveport Louisiana
Research Site Chesterfield Michigan
Research Site Tupelo Mississippi
Research Site Mexico Missouri
Research Facility Cedar Knolls New Jersey
Research Site Great Neck New York
Research Site Lake Success New York
Research Site Setauket New York
Research Site Asheville North Carolina
Research Site Greenville North Carolina
Research Facility Harrisburg North Carolina
Research Site Morganton North Carolina
Research Site Wilmington North Carolina
Research Site Winston-Salem North Carolina
Research Site Cincinnati Ohio
Research Site Cranston Rhode Island
Research Site Longview Texas
Research Site Odessa Texas
Research Site Chesapeake Virginia
Research Facility Monroe Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00554099, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 21, 2013 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00554099 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →